Sublingual Methadone for the Management of Cancer-related Breakthrough Pain in Outpatients

NCT00351715 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
5
Enrollment
OTHER
Sponsor class

Stopped Study stopped due to low accrual

Conditions

Interventions

Sponsor

AHS Cancer Control Alberta

Collaborators